Levodopa, carbidopa, ODM-104 ( DrugBank: Carbidopa, Levodopa )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	3

6. パーキンソン病

---

臨床試験数 : 2,298 /  薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03140956 (ClinicalTrials.gov)	April 19, 2017	12/4/2017	Pharmacokinetic of Levodopa Study in Healthy Males	Pharmacokinetics of Levodopa After Repeated Doses of Different Pellet Formulations; An Open, Randomized Study With Crossover Design in Healthy Male Subjects	Parkinson Disease	Drug: Levodopa, carbidopa, ODM-104	Orion Corporation, Orion Pharma	NULL	Completed	18 Years	65 Years	Male	20	Phase 1	Finland
2	NCT02554734 (ClinicalTrials.gov)	August 2015	10/6/2015	Pharmacokinetic Study in Healthy Volunteers	Pharmacokinetics of Levodopa After Repeated Doses of Carbidopa, ODM-104 and Levodopa: an Open, Randomised Study With Crossover Design in Healthy Males and Females	Parkinson's Disease	Drug: levodopa, carbidopa, ODM-104;Drug: levodopa, carbidopa, entacapone	Orion Corporation, Orion Pharma	NULL	Completed	18 Years	65 Years	Both	15	Phase 1	Finland
3	NCT02312232 (ClinicalTrials.gov)	November 2014	2/12/2014	Pharmacokinetic Study in Healthy Males	Pharmacokinetics of Levodopa, Carbidopa, 3-OMD and ODM-104 After Repeated Doses of Different Formulations: an Open, Randomised, Multicentre Study With Crossover Design in Healthy Males	Parkinson's Disease	Drug: levodopa, carbidopa, ODM-104	Orion Corporation, Orion Pharma	NULL	Completed	18 Years	65 Years	Male	20	Phase 1	Finland